120 related articles for article (PubMed ID: 37200462)
21. Delta-8 tetrahydrocannabinol: a scoping review and commentary.
LoParco CR; Rossheim ME; Walters ST; Zhou Z; Olsson S; Sussman SY
Addiction; 2023 Jun; 118(6):1011-1028. PubMed ID: 36710464
[TBL] [Abstract][Full Text] [Related]
22. Cosmetic Contact Lenses in the United Kingdom: Assessment of Online Regulation and Quality of Consumer Health Information.
Ng B; Azzopardi M; Ditchfield A; Zi J; Logeswaran A; Hawthorne I; Ting DSJ; Chong YJ
Eye Contact Lens; 2024 Jun; 50(6):243-248. PubMed ID: 38477759
[TBL] [Abstract][Full Text] [Related]
23. Unintentional ingestion of putative delta-8 tetrahydrocannabinol by two youth requiring critical care: a case report.
Bradley EK; Hoots BE; Bradley ES; Roehler DR
J Cannabis Res; 2023 Mar; 5(1):9. PubMed ID: 36941718
[TBL] [Abstract][Full Text] [Related]
24. HPLC Method for Better Separation of THC Isomers to Ensure Safety and Compliance in the Hemp Market.
Pittiglio MK; Ramirez GA; Tesfatsion TT; Ray KP; Cruces W
ACS Omega; 2024 Jun; 9(23):25390-25394. PubMed ID: 38882159
[TBL] [Abstract][Full Text] [Related]
25. Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
Lachenmeier DW; Habel S; Fischer B; Herbi F; Zerbe Y; Bock V; Rajcic de Rezende T; Walch SG; Sproll C
F1000Res; 2019; 8():1394. PubMed ID: 32117565
[TBL] [Abstract][Full Text] [Related]
26. The Reshaping of the E-Cigarette Retail Environment: Its Evolution and Public Health Concerns.
Berg CJ; Melena A; Wittman FD; Robles T; Henriksen L
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886373
[TBL] [Abstract][Full Text] [Related]
27. Illicit Internet availability of drugs subject to recall and patient safety consequences.
Mackey TK; Aung P; Liang BA
Int J Clin Pharm; 2015 Dec; 37(6):1076-85. PubMed ID: 26148859
[TBL] [Abstract][Full Text] [Related]
28. Online Retail of Derived Psychoactive Cannabis Products: Age and Shipping Restrictions.
LoParco CR; Tillett KK; Berg CJ; Rossheim ME
J Adolesc Health; 2024 Jun; ():. PubMed ID: 38864789
[TBL] [Abstract][Full Text] [Related]
29. Derived psychoactive cannabis products and 4/20 specials: An assessment of popular brands and retail price discounts in Fort Worth, Texas, 2023.
Rossheim ME; LoParco CR; Berg CJ; Tillett KK; Trangenstein PJ; Henry D; Yockey RA; Livingston MD; Jernigan DH; Sussman SY
Drug Alcohol Depend; 2024 Mar; 256():111119. PubMed ID: 38350186
[TBL] [Abstract][Full Text] [Related]
30. Uncomfortably high: Testing reveals inflated THC potency on retail Cannabis labels.
Schwabe AL; Johnson V; Harrelson J; McGlaughlin ME
PLoS One; 2023; 18(4):e0282396. PubMed ID: 37043421
[TBL] [Abstract][Full Text] [Related]
31. Association of Tetrahydrocannabinol Content and Price in Herbal Cannabis Products Offered by Dispensaries in California: A Purview of Consumers/Patients.
Dobbins M; Rakkar M; Cunnane K; Pennypacker SD; Wagoner KG; Reboussin BA; Romero-Sandoval EA
Front Public Health; 2022; 10():893009. PubMed ID: 35784239
[TBL] [Abstract][Full Text] [Related]
32. Self-reported adverse events associated with ∆
Leas EC; Harati RM; Satybaldiyeva N; Morales NE; Huffaker SL; Mejorado T; Grant I
J Cannabis Res; 2023 May; 5(1):15. PubMed ID: 37217977
[TBL] [Abstract][Full Text] [Related]
33. Acute human exposure assessment to tetrahydrocannabinol (Δ
; Arcella D; Cascio C; Mackay K
EFSA J; 2020 Jan; 18(1):e05953. PubMed ID: 32626501
[TBL] [Abstract][Full Text] [Related]
34. Cannabis regulatory system in European Union countries, forensic concept of "doping dose" and medico-legal implications.
Cioffi A; Cecannecchia C; David MC; Cipolloni L; Santurro A
Med Leg J; 2023 Sep; 91(3):128-135. PubMed ID: 37293768
[TBL] [Abstract][Full Text] [Related]
35. Establishing a Link Between Prescription Drug Abuse and Illicit Online Pharmacies: Analysis of Twitter Data.
Katsuki T; Mackey TK; Cuomo R
J Med Internet Res; 2015 Dec; 17(12):e280. PubMed ID: 26677966
[TBL] [Abstract][Full Text] [Related]
36. Exploring the e-cigarette e-commerce marketplace: Identifying Internet e-cigarette marketing characteristics and regulatory gaps.
Mackey TK; Miner A; Cuomo RE
Drug Alcohol Depend; 2015 Nov; 156():97-103. PubMed ID: 26431794
[TBL] [Abstract][Full Text] [Related]
37. A crowdsourcing survey study on the subjective effects of delta-8-tetrahydrocannabinol relative to delta-9-tetrahydrocannabinol and cannabidiol.
Bergeria CL; Strickland JC; Spindle TR; Kalaba M; Satyavolu PU; Feldner M; Vandrey R; Bonn-Miller M; Peters EN; Weerts E
Exp Clin Psychopharmacol; 2023 Apr; 31(2):312-317. PubMed ID: 35467921
[TBL] [Abstract][Full Text] [Related]
38. [Brief history of recent hemp cultivation in Switzerland and subsequent medico-legal problems resulting from hemp cultivation].
Giroud C; Broillet A; Augsburger M; Bernhard W; Rivier L; Mangin P
Praxis (Bern 1994); 1999 Jan; 88(4):113-21. PubMed ID: 10067113
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Cannabidiol, Δ
ElSohly MA; Murphy TP; Khan I; Walker LW; Gul W
Med Cannabis Cannabinoids; 2020 Aug; 3(1):1-13. PubMed ID: 34676337
[TBL] [Abstract][Full Text] [Related]
40. Δ
Schafroth MA; Mazzoccanti G; Reynoso-Moreno I; Erni R; Pollastro F; Caprioglio D; Botta B; Allegrone G; Grassi G; Chicca A; Gasparrini F; Gertsch J; Carreira EM; Appendino G
J Nat Prod; 2021 Sep; 84(9):2502-2510. PubMed ID: 34304557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
